GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $257,000 | -1.2% | 5,903 | +0.2% | 0.06% | 0.0% |
| Q4 2021 | $260,000 | +16.1% | 5,889 | +0.2% | 0.06% | 0.0% |
| Q3 2021 | $224,000 | -3.9% | 5,875 | +0.2% | 0.06% | -4.8% |
| Q2 2021 | $233,000 | +1.3% | 5,861 | -8.9% | 0.06% | -8.7% |
| Q1 2021 | $230,000 | -15.4% | 6,435 | -12.9% | 0.07% | -22.5% |
| Q4 2020 | $272,000 | -26.7% | 7,385 | -33.4% | 0.09% | -36.4% |
| Q3 2020 | $371,000 | -27.5% | 11,090 | -11.6% | 0.14% | -32.4% |
| Q2 2020 | $512,000 | -6.9% | 12,548 | -2.7% | 0.21% | -14.5% |
| Q1 2020 | $550,000 | -23.1% | 12,900 | -15.3% | 0.24% | -7.6% |
| Q4 2019 | $715,000 | +13.0% | 15,224 | +2.7% | 0.26% | -47.0% |
| Q3 2019 | $633,000 | -5.7% | 14,829 | -11.6% | 0.49% | -8.7% |
| Q2 2019 | $671,000 | -12.5% | 16,771 | -8.6% | 0.54% | -17.0% |
| Q1 2019 | $767,000 | +10.5% | 18,349 | +1.0% | 0.65% | -2.7% |
| Q4 2018 | $694,000 | – | 18,161 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |